As someone who works in an oncology clinical setting, you see patients and their families living their worst fears. While this is an experience you have every day, it is important to remember the unique circumstances of each individual you encounter. It is also imperative that you take time to access your own mechanisms for exposure to other’s trauma. In this interactive workshop, we will provide opportunities to roleplay effective patient and provider communications with a focus on empathy, active listening, and perspective taking. We will leave this session with an enhanced capacity regarding how you deal with the care environment, and a renewed understanding for how you can not only take care of others, but also yourself.
We’ve all had one: that person on your medical team that doesn’t listen to your needs and thinks they know what is best for you. Patients and caregivers can sometimes feel like they have lost their power due to well-intentioned providers not considering their unique perspectives. In this live role-play session, we will hear from a patient and a physician as they model different scenarios to help us all navigate the sometimes tumultuous relationships of patients and providers. We will leave this session with insights that we can all apply to our interactions with our medical team, turning what once made us feel powerless into power.
Day 2 Sponsored by Amgen
As a physician, Kristen has seen both tragedies and miracles in her career. As a caregiver and human, she has personally survived the loss of three family members, two to cancer. Now serving as Senior Vice President of Early Clinical Development, Hematology/Oncology & Cell Therapy at Bristol Myers Squibb (BMS), she and her team investigate new ways to transform patients’ lives through science on a daily basis. In this session, we will learn why patients are at the core of everything Kristen and her team do at BMS and hear how unique patient perspectives are helping to inform scientific discoveries. We will leave this session with a renewed understanding of the power of innovative medicines to profoundly change the course of serious human diseases, as well as BMS’ commitment to increase access and involve patients in improving care.
In the last decade, immuno-oncology treatments have transformed cancer care and brought new hope to millions of cancer patients. By harnessing the power of each person’s own immune system, immunotherapy has created new treatment options distinctly different from traditional methods. In this session, we will learn what immunotherapy is, how it works and where research is headed for the future. We will leave this session with a better understanding of immunotherapy, including vocabulary to discuss this treatment option with your oncologist.
Caregivers are undercounted, unheard, and all but invisible. They often sacrifice their health, deal with emotional isolation and lack time to care for themselves. This issue is compounded when a caregiver is a woman or a racial/ethnic minority due to the inherent inequities in our economic system and pressure from traditional family paradigms. In this session, we will discuss how we, as a society and individuals, can support caregivers to address their emotional and physical needs and create systems where we proactively help the helpers.
Clinical trials are more than a last resort option. Clinical trials are the future of medicine. Across cancer stages and types, there are trials out there for everyone. In this session, we will learn how to find clinical trials and their requirements. We will leave this session with a greater understanding of clinical trials, the kinds of trials out there for patients, and how they positively affect the future of healthcare.
Your genetic make-up and the genetic make-up of your cancer are the biggest determinants of cancer risk, the treatment you receive, and the effectiveness of that treatment. It has never been more important to understand the role that genetics plays in cancer diagnosis, treatment, and survivorship. In this session, a panel of experts will answer your questions and explain the different ways genetics plays a factor in cancer in a patient-friendly way. We will leave this session with a better understanding of the impact of genetics in cancer and what it means for you and your family.
Stage IV or metastatic cancer patients live with their disease, stuck in a time where they can’t celebrate the “survivorship” part of a cancer timeline. In this session, we will hear from folks with years of experience in the metastatic cancer community. We will leave this session with a greater understanding of how to interact with metastatic cancer patients in a way they want you to.